PurThread Technologies announces the launch of its new online store, [store.PurThread.com]. The store offers scrubs and lab coats integrated with a proprietary antimicrobial agent that protects fabrics from the damaging effects of microbial contamination. PurThread is a leading force in researching the impact of antimicrobial fabrics on the healthcare environment. In fact, PurThread's hospital privacy curtains are the only brand of hospital curtain that has been tested in a double-blinded randomized controlled trial to assess its effectiveness at reducing bioburden in a clinical setting.
The study, conducted by the University of Iowa Carver College of Medicine, found that the PurThread privacy curtains tested took seven times longer to become contaminated than control curtains. The PurThread curtains were also eight times less likely to be contaminated with VRE. PurThread is investing in research like this to assess its products' potential in clinical settings. The EPA has not yet reviewed any public health claims for PurThread products. Over time, the PurThread line of medical textiles will expand to include other linens.
"After years of research and testing on our exclusive textile technology, we are thrilled to finally announce the launch of our online store," says Bill O'Neill, PurThread vice president of infection control applications. "It provides healthcare professionals, such as nurses, doctors and administrators, with a convenient online marketplace to purchase apparel featuring our long-lasting antimicrobial agent that protects fabrics from the effects of microbial contamination."
PurThread's textile technology integrates an antimicrobial agent that produces a chemical species known as hydroxyl radicals into every fiber of the product. This provides an even distribution of the active ingredient while still keeping the fabric soft and pliable. These hydroxyl radicals attack microorganisms along several parallel pathways - simultaneously degrading the cell's protective bio film, rupturing the cellular membrane and disrupting the biological processes within the cell, thereby killing the organism. Because the agent bonds with the fabric in its raw state, the agent's efficacy can withstand the rigor of repeated laundering.
Source: PurThread Technologies, Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.